Topotecan combined with carboplatin in recurrent epithelial ovarian cancer: results of a single-institutional phase II study. [electronic resource]
Producer: 20090707Description: 210-4 p. digitalISSN:- 1095-6859
- Adult
- Aged
- Antineoplastic Combined Chemotherapy Protocols -- adverse effects
- Carboplatin -- administration & dosage
- Dose-Response Relationship, Drug
- Epithelial Cells -- pathology
- Female
- Humans
- Infusions, Intravenous
- Middle Aged
- Neoplasm Recurrence, Local -- drug therapy
- Ovarian Neoplasms -- drug therapy
- Survival Rate
- Topotecan -- administration & dosage
No physical items for this record
Publication Type: Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.